top of page

Can Psychedelics Reduce Risk Of Hypertension?




While the scientific research and exploration into the benefits of psychedelics is still very new, nearly all of the conversation on the topic has been focused on the benefits of psychedelic medicines for mental health and neurodegenerative disorders, until now...


A recent study at the University Of Oxford explored the link between psychedelic use and the risk of hypertension; the results were fascinating!


"According to the findings, a “lifetime” of use of psychedelics was linked to a 14 percent decrease in developing hypertension. Substances that contain tryptamine — psilocybin, LSD, and DMT, for example — were linked to a 20 percent decreased risk of developing hypertension, the research found. Tryptamines work with serotonin 1A receptors in the brain. They’re linked to antidepressant and potentially antihypertensive effects, the team noted."


This study opens the door for further exploration of the effects of psychedelics in cardiopulmonary conditions.


Resized_Resized_p_1667421065025 2 copy 2.JPEG

About the Author

 Anahita Anais is a nervous system expert and the founder of MicrodoseGuru,

  bringing two decades of experience in somatic healing, ceremonial work, and

  psychedelic science to her research and writing. Her work translates emerging

  clinical evidence on microdosing into practical, rigorous guidance for people

  navigating depression, anxiety, ADHD, and psychiatric medication transitions.

Microdose Guru

Begin Your Microdosing Journey Today

Download our FREE step-by-step guide on how to start Mindful Microdosing. Learn about...
  • Benefits of Microdosing

  • How to source mushrooms

  • Best practices for dosing

  • How to design a ritual 

  • Choosing a protocol

30 Pages of ACTIONABLE tips & insights!

Free Microdosing Guide
bottom of page